Charansonney, Olivier L.
Al-Dandachi, Ghanima
Plaisance, Patrick
Vicaut, Eric
Article History
Received: 31 May 2023
Accepted: 31 October 2023
First Online: 9 November 2023
Competing interests
: The clinical study was sponsored by RHEOFAST S.A.S, Evry, France. Devices were provided by RHEOFAST S.A.S.. RHEOFAST was headed by Olivier Charansonney. RHEOFAST has ended its activities. All other authors declare they have no competing interests.